PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(01): 5-9
DOI: 10.1055/s-0041-1733055
Original Article

Surface Epithelial Tumors of Ovary

RAMESH Dawar
Department of Pathology: All India Institute of Medical Sciences, New Delhi, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints


Publikationsverlauf

Artikel online veröffentlicht:
28. März 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Anreder MB, Freeman SM, Merogi A et al P 53, c-erbB2 and PCNA status in benign, prolif erative and malig¬nant ovarian surface epithelial neo plasms: a study of 75 cases . Arch Pathol Lab Med 1999; 123: 310-316
  • 2 Bast R C, Yu Y, Xu F-J et al Molecular approaches to management of epithelial ovarian cancer. Int J Gynecol Cancer 2000; 10 (suppl 1) 2-7.
  • 3 Bell K A, Sedhev AES, Kurman RJ Re fined diagnostic criteria for implants associated with ovarian atypical poliferative serous tumors (bor derline) and micropapillary serous carcinomas. Am J Surg Pathol 2001; 25: 419-432
  • 4 Boyd J, Sonoda Y, Federici MG et al Clini copathologic features of BRCA-linked and spo radic ovarian cancer. JAMA 2000; 283: 2260-2265
  • 5 Boyle P, Maisonneuve P, Autier P, Towards cancer con¬trol in women. J Epidemiol Biostat 1998; 3: 137-168.
  • 6 Banks E, Beral V, Reeves G The epidemi ology of epi¬thelial ovarian cancer: a review. Int J Gynecol Cancer 1997: 7:425-438.
  • 7 Ballouk F, Ross J S, Wolf B C Ovarian endometriotic cysts: an analysis of cytologic aty pia and DNA ploidy patterns. Am J Clin Pathol 1994; 102: 415-419.
  • 8 Crammer DW, Welch WR Determinants of ovarian cancer risk: II Inferences regarding pathogenesis. J Natl Cancer Inst 1983; 71: 717-721.
  • 9 Deligdisch L, Miranda C, Barba J, et al Ovarian Dysplasia: nuclear texture analysis. Cancer 1993; 72: 3253-3257.
  • 10 Fukunaga M, Nomura K, Ishikawa E, et al Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30: 249-255.
  • 11 Fathalla MF Incessant ovulation - a fac tor in ovarian neoplasia ? Lancet 1971; 2:163.
  • 12 Friedlander ML Prognostic factors in ovarian can¬cer. Semin Oncol 1998; 25: 305-314.
  • 13 Fujimoto J, Sakaguchi H, Hirose R, el al Biologic im¬plications of the expression of vas cular endothelial growth factor subtypes in ova rian carcinoma. Can¬cer 1998; 83: 2528-2533
  • 14 Gras E, Pons C, Machin P, et al Loss of heterozy¬gosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohis- tochemical and clinico pathological study. Int J Gynecol Pathol 2001; 20: 335- 340.
  • 15 Jiang X, Hitchcock A, Byan EJ et al Microsatellite analysis of endometriosis reveals loss of heterozy¬gosity at candidate ovarian tu mor suppressor gene loci, Cancer Res 1996; 56: 3534- 3539.
  • 16 Platz CE, Benda JA Female genital tract cancer. Cancer 1995; 75: 270-294.
  • 17 Plaxe SC, Deligdisch L, Dottino PR et al Ovarian intraepithelial neoplasia in patients with Stage I ovarian carcinoma. Gynecol Oncol 1990; 38: 367-372.
  • 18 Purdie D, Bain CJ, Siskind V, et al Hor mone replace¬ment therapy and risk of epithelial ovarian cancer. Br J Cancer 1999; 81: 559-563
  • 19 Partridge EE, Philips JL, Meneck HR The National Cancer Data Base report on ova rian cancer treat¬ment in United States hospitals. Cancer 1996; 78: 2236- 2246
  • 20 Risch HA, Marrett LD, Jain M et al Differences in risk factors for epithelial ovarian cancer by histo¬logic type: results of a case contol study. Am J of Epidemiol 1996; 144: 363-372.
  • 21 Riopel MA, Ronnett BM, Kurman RJ Evaluation of diagnostic criteria and behavior of ovarian intesti¬nal -type mucinous tumors: atypi cal proliferaive(borderline) tumors and intraepithelial, microinvasive, invasive and meta static carcinomas. Am J Surg Pathol 1999; 23: 617-635.
  • 22 Schildkrant JM, Thompson WD Familial ovarian can¬cer: a population based age control study. Am J Epidemiol 1988; 128: 456-466
  • 23 Sainzdela Cuesta R, Eichhorn JH, Rice LW, et al His¬tologic transformation of benign en dometriosis to early epithelial ovarian carcinoma. Gynecol Oncol 1996; 60: 238-244.
  • 24 Schoell WMJ, Pieber D, Reich O, et al Tumor angio¬genesis as a prognostic factor in ova rian carcinoma: quantification of immuno-reactiv ity by image analy¬sis. Cancer 1997; 80: 2257-2262
  • 25 Singleton TP, Perrone T, Oakley G, et al Activation of c-erbB-2 and prognosis in ovarian carcinoma: com¬parison with histologic type, grade and stage. Can¬cer 1994; 73: 1460-1466.
  • 26 Vaccarello L, Kanbour A, Kanbour-Shakir A, et al Tu¬mor infiltrating lymphocytes from ova rian tumors of low malignant potential. Int J Gynecol Pathol 1993; 12: 41-50.
  • 27 Weeness BA, Eltabakh GH Familial ova rian cancer and early ovarian cancer: biologic, pathologic and clinical features. Int J Gynecol Pathol 2001; 20: 48-63.
  • 28 Yancik R Ovarian cancer: age contrast in incidence, histology, disease stage at diagnosis and mortality. Cancer 1993; 71: 517-523.